Actively Recruiting

Phase Not Applicable
Age: 2Years - 17Years
All Genders
Healthy Volunteers
NCT07509359

Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children

Led by Seoul National University Hospital · Updated on 2026-04-03

96

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective randomized controlled trial aims to compare basilic vein and cephalic vein approaches for midline catheter placement in pediatric patients undergoing general anesthesia. Participants aged 2 to 17 years who require midline catheter insertion will be randomly assigned 1:1 to either the basilic vein group or the cephalic vein group. The primary outcome is the clinical blood sampling success rate during the catheter dwell period, defined as successful aspiration of ≥2 mL of blood through the midline catheter at least once without additional venipuncture. Secondary outcomes include operator-rated difficulty, number of puncture attempts, first attempt cannulation success rate, vein diameter and depth, catheter dwell time, catheter-related complications, and patient satisfaction. A total of 96 participants (48 per arm) will be enrolled at Seoul National University Children's Hospital.

CONDITIONS

Official Title

Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children

Who Can Participate

Age: 2Years - 17Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 2 to 17 years undergoing general anesthesia
  • Midline catheter placement is needed as determined by the anesthesiologist based on at least one of the following: expected 2 or more blood draws after surgery; expected blood loss 40% or more of estimated blood volume; continuous antibiotic therapy; hospitalization for 7 or more days; surgical team request
Not Eligible

You will not qualify if you...

  • Requirement for central venous catheter as decided by the surgical team
  • Presence of coagulopathy (blood clotting disorder)
  • History of severe thrombosis
  • Other reasons determined by the investigators making the participant ineligible

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hee-Soo Kim

Seoul, Soul-t'ukpyolsi, South Korea, 03080

Actively Recruiting

Loading map...

Research Team

J

Jung-Bin Park, MDPhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here